☰

Andrew Gray, Ph.D. - Publications

Affiliations: 
2011 Genetic, Molecular, and Cell Biology University of Southern California, Los Angeles, CA, United States 
Area:
Immunology, Oncology, Cell Biology
Tree Info Grants Similar researchers PubMed Report error

8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Yan L, Silva DM, Verma B, Gray A, Brand HE, Skeate JG, Porras TB, Kanodia S, Kast WM. Forced LIGHT expression in prostate tumors overcomes Treg mediated immunosuppression and synergizes with a prostate tumor therapeutic vaccine by recruiting effector T lymphocytes. The Prostate. 75: 280-91. PMID 25399517 DOI: 10.1002/Pros.22914  0.566
2010 Gray A, Yan L, Kast WM. Prevention is better than cure: the case for clinical trials of therapeutic cancer vaccines in the prophylactic setting. Molecular Interventions. 10: 197-203. PMID 20729485 DOI: 10.1124/mi.10.4.2  0.486
2009 Gray A, de la Luz Garcia-Hernandez M, van West M, Kanodia S, Hubby B, Kast WM. Prostate cancer immunotherapy yields superior long-term survival in TRAMP mice when administered at an early stage of carcinogenesis prior to the establishment of tumor-associated immunosuppression at later stages. Vaccine. 27: G52-9. PMID 20006141 DOI: 10.1016/J.Vaccine.2009.09.106  0.596
2009 Koh YT, Gray A, Higgins SA, Hubby B, Kast WM. Androgen ablation augments prostate cancer vaccine immunogenicity only when applied after immunization. The Prostate. 69: 571-84. PMID 19143030 DOI: 10.1002/Pros.20906  0.658
2009 Raff AB, Gray A, Kast WM. Prostate stem cell antigen: a prospective therapeutic and diagnostic target. Cancer Letters. 277: 126-32. PMID 18838214 DOI: 10.1016/J.Canlet.2008.08.034  0.569
2008 Gray A, Raff AB, Chiriva-Internati M, Chen SY, Kast WM. A paradigm shift in therapeutic vaccination of cancer patients: the need to apply therapeutic vaccination strategies in the preventive setting. Immunological Reviews. 222: 316-27. PMID 18364011 DOI: 10.1111/J.1600-065X.2008.00605.X  0.571
2008 Garcia-Hernandez Mde L, Gray A, Hubby B, Klinger OJ, Kast WM. Prostate stem cell antigen vaccination induces a long-term protective immune response against prostate cancer in the absence of autoimmunity. Cancer Research. 68: 861-9. PMID 18245488 DOI: 10.1158/0008-5472.Can-07-0445  0.605
2007 Garcia-Hernandez Mde L, Gray A, Hubby B, Kast WM. In vivo effects of vaccination with six-transmembrane epithelial antigen of the prostate: a candidate antigen for treating prostate cancer. Cancer Research. 67: 1344-51. PMID 17283172 DOI: 10.1158/0008-5472.Can-06-2996  0.572
Show low-probability matches.